{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:21:26Z","timestamp":1794565286666,"version":"4.9.1"},"reference-count":363,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T00:00:00Z","timestamp":1609113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004482","name":"Kuwait University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004482","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003286","name":"Kuwait Foundation for the Advancement of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.biopha.2020.111193","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T08:51:16Z","timestamp":1610095876000},"page":"111193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury"],"prefix":"10.1016","volume":"136","author":[{"given":"Murat","family":"Oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1821-8801","authenticated-orcid":false,"given":"Dietrich Ernst","family":"Lorke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib0005","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"issue":"43","key":"10.1016\/j.biopha.2020.111193_bib0010","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2020.111193_bib0015","series-title":"The Protective Arm of the Renin Angiotensin System: Functional Aspects and Therapeutic Implications","first-page":"185","article-title":"ACE2 cell biology, regulation, and physiological functions","author":"Turner","year":"2015"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0020","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.06.003","article-title":"Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters","volume":"128","author":"Kuba","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib0025","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4161\/chan.5.5.16470","article-title":"Collectrin and ACE2 in renal and intestinal amino acid transport","volume":"5","author":"Singer","year":"2011","journal-title":"Channels (Austin)"},{"issue":"17","key":"10.1016\/j.biopha.2020.111193_bib0030","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/157340811795713756","article-title":"Ectodomain shedding of ACE and ACE2 as regulators of their protein functions","volume":"7","author":"Iwata","year":"2011","journal-title":"Curr. Enzym. Inhib."},{"issue":"9","key":"10.1016\/j.biopha.2020.111193_bib0040","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jacc.2008.02.088","article-title":"Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system","volume":"52","author":"Epelman","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib0045","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/01.HYP.0000244543.91937.79","article-title":"Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study","volume":"48","author":"Rice","year":"2006","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCRESAHA.116.310509","article-title":"Clinical relevance and role of neuronal AT1 receptors in ADAM17-mediated ACE2 shedding in neurogenic hypertension","volume":"121","author":"Xu","year":"2017","journal-title":"Circ. Res."},{"issue":"34","key":"10.1016\/j.biopha.2020.111193_bib0055","doi-asserted-by":"crossref","first-page":"30113","DOI":"10.1074\/jbc.M505111200","article-title":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)","volume":"280","author":"Lambert","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2020.111193_bib0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","article-title":"Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS","volume":"66","author":"Patel","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6618","key":"10.1016\/j.biopha.2020.111193_bib0065","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor-\u03b1 from cells","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"issue":"6618","key":"10.1016\/j.biopha.2020.111193_bib0070","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/385733a0","article-title":"Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha","volume":"385","author":"Moss","year":"1997","journal-title":"Nature"},{"issue":"41","key":"10.1016\/j.biopha.2020.111193_bib0075","doi-asserted-by":"crossref","first-page":"35466","DOI":"10.1074\/jbc.M111.277434","article-title":"Reactive oxygen species and p38 mitogen-activated protein kinase mediate tumor necrosis factor \u03b1-converting enzyme (TACE\/ADAM-17) activation in primary human monocytes","volume":"286","author":"Scott","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0080","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.molcel.2010.01.034","article-title":"Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation","volume":"37","author":"Xu","year":"2010","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0085","doi-asserted-by":"crossref","first-page":"L84","DOI":"10.1152\/ajplung.00071.2009","article-title":"Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia","volume":"297","author":"Jia","year":"2009","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0090","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.febslet.2007.11.085","article-title":"Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain","volume":"582","author":"Lambert","year":"2008","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib0095","doi-asserted-by":"crossref","first-page":"F629","DOI":"10.1152\/ajprenal.00516.2013","article-title":"Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice","volume":"306","author":"Salem","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0100","doi-asserted-by":"crossref","first-page":"e62833","DOI":"10.1371\/journal.pone.0062833","article-title":"Rosiglitazone treatment of type 2 diabetic db\/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion","volume":"8","author":"Chodavarapu","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib0105","doi-asserted-by":"crossref","first-page":"F534","DOI":"10.1152\/ajprenal.00082.2015","article-title":"Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria","volume":"310","author":"Riera","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1530\/JOE-13-0532","article-title":"Daily exercise training protects against albuminuria and angiotensin converting enzyme 2 shedding in db\/db diabetic mice","volume":"221","author":"Somineni","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.biopha.2020.111193_bib0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fphys.2016.00469","article-title":"A disintegrin and metalloprotease 17 in the cardiovascular and central nervous systems","volume":"7","author":"Xu","year":"2016","journal-title":"Front. Physiol."},{"issue":"30","key":"10.1016\/j.biopha.2020.111193_bib0120","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.2174\/0929867324666170414162841","article-title":"Circulating ACE2 in cardiovascular and kidney diseases","volume":"24","author":"Anguiano","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0125","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/pr.118.017129","article-title":"Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure","volume":"71","author":"Arendse","year":"2019","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0130","doi-asserted-by":"crossref","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","article-title":"Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?","volume":"310","author":"Chappell","year":"2016","journal-title":"Am. J. Physiol. Heart Circulatory Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0135","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0140","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1-7)\/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib0145","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2353\/ajpath.2008.070762","article-title":"Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK\/p38 MAP kinase pathway","volume":"172","author":"Koka","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib0150","doi-asserted-by":"crossref","first-page":"C1169","DOI":"10.1152\/ajpcell.00145.2008","article-title":"MAP kinase\/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides","volume":"295","author":"Gallagher","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib0155","doi-asserted-by":"crossref","first-page":"H2373","DOI":"10.1152\/ajpheart.00426.2008","article-title":"Regulation of ACE2 in cardiac myocytes and fibroblasts","volume":"295","author":"Gallagher","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2020.111193_bib0160","doi-asserted-by":"crossref","first-page":"C1073","DOI":"10.1152\/ajpcell.00364.2012","article-title":"Angiotensin II regulates ACE and ACE2 in neurons through p38 mitogen-activated protein kinase and extracellular signal-regulated kinase 1\/2 signaling","volume":"304","author":"Xiao","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib0165","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","article-title":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism","volume":"64","author":"Deshotels","year":"2014","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.biopha.2020.111193_bib0170","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/CIRCRESAHA.113.301811","article-title":"Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension","volume":"113","author":"Xia","year":"2013","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0175","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2012.11.004","article-title":"Interaction between TGF-\u03b2 and ACE2-Ang-(1-7)-Mas pathway in high glucose-cultured NRK-52E cells","volume":"366","author":"Chou","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2020.111193_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109193","article-title":"Exogenous angiotensin (1-7) directly inhibits epithelial-mesenchymal transformation induced by transforming growth factor-\u03b21 in alveolar epithelial cells","volume":"117","author":"Shao","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0185","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","volume":"98","author":"Su","year":"2020","journal-title":"Kidney Int."},{"issue":"5\u20136","key":"10.1016\/j.biopha.2020.111193_bib0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000350395","article-title":"Endothelin-1 downregulates angiotensin-converting enzyme-2 expression in human bronchial epithelial cells","volume":"91","author":"Zhang","year":"2013","journal-title":"Pharmacology"},{"issue":"12","key":"10.1016\/j.biopha.2020.111193_bib0195","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/sj.ki.5001509","article-title":"Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells","volume":"69","author":"Su","year":"2006","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0200","doi-asserted-by":"crossref","first-page":"C420","DOI":"10.1152\/ajpcell.00409.2004","article-title":"Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes","volume":"290","author":"Gallagher","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"9","key":"10.1016\/j.biopha.2020.111193_bib0205","doi-asserted-by":"crossref","first-page":"H1007","DOI":"10.1152\/ajpheart.00563.2014","article-title":"Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy","volume":"308","author":"Hao","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2020.111193_bib0210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.regpep.2012.04.002","article-title":"Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells","volume":"177","author":"Xue","year":"2012","journal-title":"Regul. Pept."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0215","doi-asserted-by":"crossref","first-page":"F337","DOI":"10.1152\/ajprenal.90437.2008","article-title":"Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells","volume":"296","author":"Zimpelmann","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2020.111193_bib0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000441606","article-title":"Angiotensin-(1-7)\/mas signaling inhibits lipopolysaccharide-induced ADAM17 shedding activity and apoptosis in alveolar epithelial cells","volume":"97","author":"Ma","year":"2016","journal-title":"Pharmacology"},{"key":"10.1016\/j.biopha.2020.111193_bib0225","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.yjmcc.2017.11.018","article-title":"DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17\/ACE2 and GSK-3\u03b2\/\u03b2-catenin pathways","volume":"114","author":"Zhai","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0230","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1124\/pr.119.017533","article-title":"International union of basic and clinical pharmacology. CVII. Structure and pharmacology of the apelin receptor with a recommendation that Elabela\/Toddler is a second endogenous peptide ligand","volume":"71","author":"Read","year":"2019","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0235","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/HYPERTENSIONAHA.115.06892","article-title":"Angiotensin-converting enzyme 2 metabolizes and partially inactivates Pyr-Apelin-13 and Apelin-17: physiological effects in the cardiovascular system","volume":"68","author":"Wang","year":"2016","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib0240","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/HYPERTENSIONAHA.117.10156","article-title":"Apelin is a negative regulator of angiotensin II-Mediated adverse myocardial remodeling and dysfunction","volume":"70","author":"Zhang","year":"2017","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.biopha.2020.111193_bib0245","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/cvr\/cvx061","article-title":"ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage","volume":"113","author":"Sato","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"12","key":"10.1016\/j.biopha.2020.111193_bib0250","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1172\/JCI69608","article-title":"Apelin is a positive regulator of ACE2 in failing hearts","volume":"123","author":"Sato","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib0255","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/13813455.2018.1453521","article-title":"Interactive effects of apelin, renin-angiotensin system and nitric oxide in treatment of obesity-induced type 2 diabetes mellitus in male albino rats","volume":"125","author":"Sabry","year":"2019","journal-title":"Arch. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0260","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1172\/JCI128469","article-title":"Apelin directs endothelial cell differentiation and vascular repair following immune-mediated injury","volume":"130","author":"Masoud","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020239","article-title":"Loss of apelin augments angiotensin II-induced cardiac dysfunction and pathological remodeling","volume":"20","author":"Sato","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0270","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/j.2040-4603.2011.tb00347.x","article-title":"The kallikrein-kinin system as a regulator of cardiovascular and renal function","volume":"1","author":"Rhaleb","year":"2011","journal-title":"Compr. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0275","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.HYP.34.2.296","article-title":"Angiotensin-(1-7) is a modulator of the human renin-angiotensin system","volume":"34","author":"Roks","year":"1999","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0280","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/01.HYP.38.1.95","article-title":"Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade","volume":"38","author":"Tom","year":"2001","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib0285","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/FJC.0000000000000069","article-title":"Angiotensin-(1-7) augments endothelium-dependent relaxations of porcine coronary arteries to bradykinin by inhibiting angiotensin-converting enzyme 1","volume":"63","author":"Raffai","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0290","doi-asserted-by":"crossref","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","article-title":"Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg(9) bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration","volume":"314","author":"Sodhi","year":"2018","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2020.111193_bib0295","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2014.09.001","article-title":"Des-Arg9-bradykinin causes kinin B1 receptor mediated endothelium-independent contractions in endotoxin-treated porcine coronary arteries","volume":"90","author":"More","year":"2014","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0300","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canlet.2010.09.020","article-title":"Activation of kinin B1 receptor increases the release of metalloproteases-2 and -9 from both estrogen-sensitive and -insensitive breast cancer cells","volume":"301","author":"Ehrenfeld","year":"2011","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.biopha.2020.111193_bib0305","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/exd.13038","article-title":"Activation of the human keratinocyte B1 bradykinin receptor induces expression and secretion of metalloproteases 2 and 9 by transactivation of epidermal growth factor receptor","volume":"25","author":"Matus","year":"2016","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib0310","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1124\/jpet.110.168054","article-title":"Bradykinin decreases podocyte permeability through ADAM17-dependent epidermal growth factor receptor activation and zonula occludens-1 rearrangement","volume":"334","author":"Dey","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2020.111193_bib0315","series-title":"Nicotinic Acetylcholine Receptor Technologies","first-page":"171","article-title":"\u03b17-nicotinic acetylcholine receptors and \u03b2-amyloid peptides in Alzheimer\u2019s disease","author":"Lorke","year":"2016"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0320","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(99)00827-7","article-title":"Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population","volume":"277","author":"Hu","year":"1999","journal-title":"Neurosci. Lett."},{"issue":"51","key":"10.1016\/j.biopha.2020.111193_bib0325","doi-asserted-by":"crossref","first-page":"47863","DOI":"10.1074\/jbc.M104068200","article-title":"Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity","volume":"276","author":"Hu","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.biopha.2020.111193_bib0330","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1523\/JNEUROSCI.1549-07.2007","article-title":"Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition","volume":"27","author":"Zou","year":"2007","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.biopha.2020.111193_bib0335","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/jnr.23404","article-title":"Conversion of A\u03b243 to A\u03b240 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme","volume":"92","author":"Liu","year":"2014","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0340","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13195-016-0217-7","article-title":"Angiotensin-converting enzyme 2 is reduced in Alzheimer\u2019s disease in association with increasing amyloid-\u03b2 and tau pathology","volume":"8","author":"Kehoe","year":"2016","journal-title":"Alzheimers Res. Ther."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2020.111193_bib0345","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12868-018-0412-5","article-title":"Modulation of the expression of genes related to the system of amyloid-beta metabolism in the brain as a novel mechanism of ceftriaxone neuroprotective properties","volume":"19","author":"Tikhonova","year":"2018","journal-title":"BMC Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0350","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-190721","article-title":"Cerebrospinal fluid changes in the renin-angiotensin system in Alzheimer\u2019s disease","volume":"72","author":"Kehoe","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2020.111193_bib0355","doi-asserted-by":"crossref","first-page":"16024","DOI":"10.1038\/npjamd.2016.24","article-title":"Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function","volume":"2","author":"Wang","year":"2016","journal-title":"NPJ Aging Mech. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib0360","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00401-019-02098-6","article-title":"ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"139","author":"Evans","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.biopha.2020.111193_bib0365","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1007\/s12035-018-0966-3","article-title":"Stimulation of ACE2\/ANG(1-7)\/mas axis by diminazene ameliorates Alzheimer\u2019s disease in the D-Galactose-Ovariectomized rat model: role of PI3K\/Akt pathway","volume":"55","author":"Kamel","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"14","key":"10.1016\/j.biopha.2020.111193_bib0370","doi-asserted-by":"crossref","first-page":"14819","DOI":"10.18632\/aging.103544","article-title":"ACE2 activator diminazene aceturate ameliorates Alzheimer\u2019s disease-like neuropathology and rescues cognitive impairment in SAMP8 mice","volume":"12","author":"Duan","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.biopha.2020.111193_bib0375","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1167\/iovs.17-21546","article-title":"Overexpression of angiotensin-converting enzyme 2 ameliorates amyloid \u03b2-Induced inflammatory response in human primary retinal pigment epithelium","volume":"58","author":"Fu","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2020.111193_bib0380","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neuroscience.2017.01.027","article-title":"Angiotensin-(1-7) administration attenuates Alzheimer\u2019s disease-like neuropathology in rats with streptozotocin-induced diabetes via Mas receptor activation","volume":"346","author":"Chen","year":"2017","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0385","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-150642","article-title":"Intracerebroventricular infusion of angiotensin-(1-7) ameliorates cognitive impairment and memory dysfunction in a mouse model of alzheimer\u2019s disease","volume":"53","author":"Uekawa","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0390","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/1567202613666160224124739","article-title":"Plasma angiotensin-(1-7) is a potential biomarker for Alzheimer\u2019s disease","volume":"13","author":"Jiang","year":"2016","journal-title":"Curr. Neurovasc. Res."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0395","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s12035-015-9260-9","article-title":"Angiotensin-(1-7) is reduced and inversely correlates with tau hyperphosphorylation in animal models of Alzheimer\u2019s disease","volume":"53","author":"Jiang","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0400","doi-asserted-by":"crossref","first-page":"645","DOI":"10.18632\/aging.101419","article-title":"AVE0991, a nonpeptide analogue of Ang-(1-7), attenuates aging-related neuroinflammation","volume":"10","author":"Jiang","year":"2018","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0405","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.118.254854","article-title":"A novel angiotensin-(1-7) glycosylated mas receptor agonist for treating vascular cognitive impairment and inflammation-related memory dysfunction","volume":"369","author":"Hay","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1\u20134","key":"10.1016\/j.biopha.2020.111193_bib0410","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000333340","article-title":"Side-chain-oxidized oxysterols upregulate ACE2 and Mas receptor in rat primary neurons","volume":"10","author":"Mateos","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.biopha.2020.111193_bib0415","article-title":"Angiotensin-converting enzyme 2 (ACE2) is upregulated in Alzheimer\u2019s disease brain","author":"Ding","year":"2020","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib0420","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.jinf.2020.06.072","article-title":"Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer\u2019s disease","volume":"81","author":"Lim","year":"2020","journal-title":"J. Infect."},{"issue":"10","key":"10.1016\/j.biopha.2020.111193_bib0425","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1042\/CS20180189","article-title":"The depressor axis of the renin-angiotensin system and brain disorders: a translational approach","volume":"132","author":"Gironacci","year":"2018","journal-title":"Clin Sci. (Lond)"},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0430","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3233\/JAD-181035","article-title":"Contributions by the brain renin-angiotensin system to memory, cognition, and Alzheimer\u2019s disease","volume":"67","author":"Wright","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib0435","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/micc.12193","article-title":"Angiotensin and neurovascular coupling: beyond hypertension","volume":"22","author":"Bloch","year":"2015","journal-title":"Microcirculation"},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0440","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11906-018-0810-1","article-title":"Integrative physiological aspects of brain RAS in hypertension","volume":"20","author":"de Morais","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0445","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1753944715578056","article-title":"The compensatory renin-angiotensin system in the central regulation of arterial pressure: new avenues and new challenges","volume":"9","author":"Mendoza","year":"2015","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib0450","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/HYPERTENSIONAHA.119.13133","article-title":"ACE2 and ADAM17 interaction regulates the activity of presympathetic neurons","volume":"74","author":"Mukerjee","year":"2019","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib0455","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/HYPERTENSIONAHA.114.04691","article-title":"Brain-targeted angiotensin-converting enzyme 2 overexpression attenuates neurogenic hypertension by inhibiting cyclooxygenase-mediated inflammation","volume":"65","author":"Sriramula","year":"2015","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0460","first-page":"456","article-title":"Gene transfer of angiotensin-converting enzyme 2 in the nucleus tractus solitarius improves baroreceptor heart rate reflex in spontaneously hypertensive rats","volume":"12","author":"Yamazato","year":"2011","journal-title":"J. Renin. Syst."},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib0465","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s11064-018-2679-4","article-title":"ACE2 in brain physiology and pathophysiology: evidence from transgenic animal models","volume":"44","author":"Alenina","year":"2019","journal-title":"Neurochem. Res."},{"issue":"7122","key":"10.1016\/j.biopha.2020.111193_bib0470","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nature05475","article-title":"Essential role for collectrin in renal amino acid transport","volume":"444","author":"Danilczyk","year":"2006","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.biopha.2020.111193_bib0475","doi-asserted-by":"crossref","first-page":"17132","DOI":"10.1074\/jbc.M006723200","article-title":"Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys","volume":"276","author":"Zhang","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0480","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1253\/circj.CJ-12-1544","article-title":"Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases","volume":"77","author":"Kuba","year":"2013","journal-title":"Circ. J."},{"issue":"13","key":"10.1016\/j.biopha.2020.111193_bib0485","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.micinf.2013.08.003","article-title":"ACE2 - from the renin-angiotensin system to gut microbiota and malnutrition","volume":"15","author":"Perlot","year":"2013","journal-title":"Microbes Infect."},{"issue":"6485","key":"10.1016\/j.biopha.2020.111193_bib0490","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0495","doi-asserted-by":"crossref","first-page":"F533","DOI":"10.1152\/ajprenal.00325.2006","article-title":"Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin","volume":"292","author":"Malakauskas","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib0500","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1053\/j.gastro.2008.10.055","article-title":"Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations","volume":"136","author":"Camargo","year":"2009","journal-title":"Gastroenterology"},{"issue":"7408","key":"10.1016\/j.biopha.2020.111193_bib0505","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature11228","article-title":"ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation","volume":"487","author":"Hashimoto","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0510","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BJ20120307","article-title":"Intestinal peptidases form functional complexes with the neutral amino acid transporter B(0)AT1","volume":"446","author":"Fairweather","year":"2012","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib0515","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbadis.2004.05.005","article-title":"Interaction of ACE2 and integrin \u03b21 in failing human heart","volume":"1689","author":"Lin","year":"2004","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0520","doi-asserted-by":"crossref","first-page":"e34747","DOI":"10.1371\/journal.pone.0034747","article-title":"Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling","volume":"7","author":"Clarke","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.111193_bib0525","article-title":"The integrin binding peptide, ATN-161, as a novel therapy for SARS-CoV-2 infection","author":"Beddingfield","year":"2020","journal-title":"JACC"},{"key":"10.1016\/j.biopha.2020.111193_bib0530","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-micro-020518-115759","article-title":"Human coronavirus: host-pathogen interaction","volume":"73","author":"Fung","year":"2019","journal-title":"Annu. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0535","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2020.03.035","article-title":"A genomic perspective on the origin and emergence of SARS-CoV-2","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib0540","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0545","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0550","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.biopha.2020.111193_bib0555","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1073\/pnas.0409465102","article-title":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry","volume":"102","author":"Hofmann","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6965","key":"10.1016\/j.biopha.2020.111193_bib0560","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"7798","key":"10.1016\/j.biopha.2020.111193_bib0565","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"6483","key":"10.1016\/j.biopha.2020.111193_bib0570","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.biopha.2020.111193_bib0575","doi-asserted-by":"crossref","first-page":"e00127","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2020.111193_bib0580","first-page":"1","article-title":"Naturally occurring SARS-CoV-2 gene deletions close to the spike S1\/S2 cleavage site in the viral quasispecies of COVID19 patients","author":"Andres","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0585","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1080\/22221751.2020.1781551","article-title":"Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site","volume":"9","author":"Jin","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.biopha.2020.111193_bib0590","article-title":"Missense variants in ACE2 are predicted to encourage and inhibit interaction with SARS-CoV-2 Spike and contribute to genetic risk in COVID-19","author":"MacGowan","year":"2020","journal-title":"bioRxiv"},{"issue":"5742","key":"10.1016\/j.biopha.2020.111193_bib0595","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.biopha.2020.111193_bib0600","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.emboj.7600640","article-title":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2","volume":"24","author":"Li","year":"2005","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0605","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/cr.2016.152","article-title":"Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding","volume":"27","author":"Gui","year":"2017","journal-title":"Cell Res."},{"issue":"21","key":"10.1016\/j.biopha.2020.111193_bib0610","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0615","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0620","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib0625","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.antiviral.2013.09.028","article-title":"Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research","volume":"100","author":"Simmons","year":"2013","journal-title":"Antiviral Res."},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib0630","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2020.111193_bib0635","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res."},{"issue":"18","key":"10.1016\/j.biopha.2020.111193_bib0640","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1128\/JVI.01001-12","article-title":"Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain","volume":"86","author":"Schneider","year":"2012","journal-title":"J. Virol."},{"issue":"35","key":"10.1016\/j.biopha.2020.111193_bib0645","doi-asserted-by":"crossref","first-page":"12543","DOI":"10.1073\/pnas.0503203102","article-title":"Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection","volume":"102","author":"Matsuyama","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"9","key":"10.1016\/j.biopha.2020.111193_bib0650","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib0655","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01815-18","article-title":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection","volume":"93","author":"Iwata-Yoshikawa","year":"2019","journal-title":"J. Virol."},{"issue":"13","key":"10.1016\/j.biopha.2020.111193_bib0660","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.2002589117","article-title":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells","volume":"117","author":"Matsuyama","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"12","key":"10.1016\/j.biopha.2020.111193_bib0665","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/JVI.00094-12","article-title":"Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry","volume":"86","author":"Kawase","year":"2012","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib0670","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00754-20","article-title":"Nafamostat mesylate blocks activation of SARS-CoV-2: new treatment option for COVID-19","volume":"64","author":"Hoffmann","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2020.111193_bib0675","doi-asserted-by":"crossref","first-page":"144944","DOI":"10.1016\/j.gene.2020.144944","article-title":"SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I\/D genotype","volume":"758","author":"Yamamoto","year":"2020","journal-title":"Gene"},{"issue":"11","key":"10.1016\/j.biopha.2020.111193_bib0680","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/2159-8290.CD-13-1010","article-title":"The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis","volume":"4","author":"Lucas","year":"2014","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.biopha.2020.111193_bib0685","doi-asserted-by":"crossref","first-page":"e105114","DOI":"10.15252\/embj.20105114","article-title":"SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells","volume":"39","author":"Lukassen","year":"2020","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0690","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/1042517021000021608","article-title":"Molecular cloning, mRNA expression and chromosomal localization of mouse angiotensin-converting enzyme-related carboxypeptidase (mACE2)","volume":"13","author":"Komatsu","year":"2002","journal-title":"DNA Seq."},{"issue":"17","key":"10.1016\/j.biopha.2020.111193_bib0695","first-page":"4180","article-title":"Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2","volume":"59","author":"Lin","year":"1999","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2020.111193_bib0700","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mce.2009.12.022","article-title":"Androgen receptor and androgen-dependent gene expression in lung","volume":"317","author":"Mikkonen","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib0705","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1158\/2159-8290.CD-20-0451","article-title":"TMPRSS2 and COVID-19: serendipity or opportunity for intervention?","volume":"10","author":"Stopsack","year":"2020","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.biopha.2020.111193_bib0710","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.4049\/jimmunol.1601896","article-title":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection","volume":"198","author":"Channappanavar","year":"2017","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2020.111193_bib0715","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082948","article-title":"Sex-specific SARS-CoV-2 mortality: among hormone-modulated ACE2 expression, risk of venous thromboembolism and hypovitaminosis d","volume":"21","author":"La Vignera","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2020.111193_bib0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104742","article-title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","volume":"176","author":"Coutard","year":"2020","journal-title":"Antiviral Res."},{"issue":"8","key":"10.1016\/j.biopha.2020.111193_bib0725","doi-asserted-by":"crossref","first-page":"e1073","DOI":"10.1002\/cti2.1073","article-title":"Furin-mediated protein processing in infectious diseases and cancer","volume":"8","author":"Braun","year":"2019","journal-title":"Clin. Transl. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0730","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/joim.12783","article-title":"Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality","volume":"284","author":"Fernandez","year":"2018","journal-title":"J. Intern. Med."},{"issue":"29","key":"10.1016\/j.biopha.2020.111193_bib0735","doi-asserted-by":"crossref","first-page":"20847","DOI":"10.1074\/jbc.M703847200","article-title":"Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens","volume":"282","author":"Shiryaev","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2020.111193_bib0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108254","article-title":"Furin inhibitors block SARS-CoV-2 spike protein cleavage to suppress virus production and cytopathic effects. Available at SSRN","author":"Cheng","year":"2020","journal-title":"Cell Rep."},{"issue":"16","key":"10.1016\/j.biopha.2020.111193_bib0745","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1128\/JVI.00253-07","article-title":"Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted","volume":"81","author":"Inoue","year":"2007","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0750","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/cr.2008.15","article-title":"SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway","volume":"18","author":"Wang","year":"2008","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0755","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0760","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2020.111193_bib0765","series-title":"Activation of Viruses by Host Proteases","first-page":"71","article-title":"Priming time: how cellular proteases arm coronavirus spike proteins","author":"Hoffmann","year":"2018"},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib0770","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1161\/01.HYP.0000146120.29648.36","article-title":"Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor","volume":"44","author":"Huentelman","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2020.111193_bib0775","article-title":"High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity","author":"Lu","year":"2020","journal-title":"bioRxiv"},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0780","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbrc.2004.05.114","article-title":"Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor","volume":"319","author":"Hofmann","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib0785","doi-asserted-by":"crossref","first-page":"C1318","DOI":"10.1152\/ajpcell.00036.2009","article-title":"Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor alpha-converting enzyme","volume":"297","author":"Iwata","year":"2009","journal-title":"Am. J. Physiol., Cell Physiol."},{"issue":"22","key":"10.1016\/j.biopha.2020.111193_bib0790","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1073\/pnas.0711241105","article-title":"Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry","volume":"105","author":"Haga","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0795","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/iid3.366","article-title":"Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells","volume":"8","author":"Yang","year":"2020","journal-title":"Immunity, Inflammation Dis."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0800","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.virol.2008.08.016","article-title":"Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratory syndrome coronavirus in Chinese macaques","volume":"381","author":"Chen","year":"2008","journal-title":"Virology"},{"issue":"23","key":"10.1016\/j.biopha.2020.111193_bib0805","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","article-title":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia","volume":"79","author":"Jia","year":"2005","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0810","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.virol.2007.04.035","article-title":"The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2","volume":"367","author":"Li","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.biopha.2020.111193_bib0815","series-title":"A Comprehensive Guide to the Pharmacologic Regulation of Angiotensin Converting Enzyme 2 (ACE2), the SARS-CoV-2 Entry Receptor Pharmacology & Therapeutics","author":"Oz","year":"2021"},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib0820","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/infdis\/jiy574","article-title":"Elevated human dipeptidyl peptidase 4 expression reduces the susceptibility of hDPP4 transgenic mice to middle east respiratory syndrome coronavirus infection and disease","volume":"219","author":"Algaissi","year":"2019","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.biopha.2020.111193_bib0825","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.biopha.2020.111193_bib0830","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur. J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.biopha.2020.111193_bib0835","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","article-title":"SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function","volume":"21","author":"Winkler","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2020.111193_bib0840","article-title":"SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE2","author":"Lei","year":"2020","journal-title":"bioRxiv"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2020.111193_bib0845","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virusres.2008.03.004","article-title":"Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2","volume":"136","author":"Wang","year":"2008","journal-title":"Virus Res."},{"issue":"9","key":"10.1016\/j.biopha.2020.111193_bib0850","doi-asserted-by":"crossref","first-page":"12234","DOI":"10.1021\/acsnano.0c05975","article-title":"Quantum dot-conjugated SARS-CoV-2 spike pseudo-virions enable tracking of angiotensin converting enzyme 2 binding and endocytosis","volume":"14","author":"Gorshkov","year":"2020","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0855","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.02062-10","article-title":"A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry","volume":"85","author":"Shulla","year":"2011","journal-title":"J. Virol."},{"issue":"2642","key":"10.1016\/j.biopha.2020.111193_bib0860","article-title":"ACE2\/ADAM17\/TMPRSS2 interplay may be the main risk factor for COVID-19","volume":"11","author":"Zipeto","year":"2020","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.biopha.2020.111193_bib0865","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1128\/JVI.02560-09","article-title":"Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus Spike-ACE2 signaling pathway","volume":"84","author":"Chen","year":"2010","journal-title":"J. Virol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2020.111193_bib0870","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virusres.2009.01.005","article-title":"SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro","volume":"142","author":"Dosch","year":"2009","journal-title":"Virus Res."},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib0875","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.2067","article-title":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS","volume":"210","author":"He","year":"2006","journal-title":"J. Pathol."},{"issue":"14","key":"10.1016\/j.biopha.2020.111193_bib0880","doi-asserted-by":"crossref","first-page":"7062","DOI":"10.1128\/JVI.00127-09","article-title":"Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection","volume":"83","author":"Rockx","year":"2009","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0885","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.virol.2006.06.011","article-title":"Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells","volume":"353","author":"de Lang","year":"2006","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib0890","doi-asserted-by":"crossref","first-page":"e63847","DOI":"10.1371\/journal.pone.0063847","article-title":"Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension","volume":"8","author":"Sriramula","year":"2013","journal-title":"PLoS One"},{"issue":"Pt 9","key":"10.1016\/j.biopha.2020.111193_bib0895","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1099\/vir.0.043919-0","article-title":"Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63","volume":"93","author":"Dijkman","year":"2012","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0900","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/fvl.10.4","article-title":"Renin-angiotensin system in human coronavirus pathogenesis","volume":"5","author":"Wevers","year":"2010","journal-title":"Future Virol."},{"key":"10.1016\/j.biopha.2020.111193_bib0905","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virusres.2014.03.010","article-title":"Downregulation of angiotensin-converting enzyme 2 by the neuraminidase protein of influenza A (H1N1) virus","volume":"185","author":"Liu","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.biopha.2020.111193_bib0910","doi-asserted-by":"crossref","first-page":"101833","DOI":"10.1016\/j.pupt.2019.101833","article-title":"Renin-angiotensin-system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation","volume":"58","author":"Wang","year":"2019","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0915","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/path.2987","article-title":"Acute respiratory distress syndrome leads to reduced ratio of ACE\/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist","volume":"225","author":"Wosten-van Asperen","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.biopha.2020.111193_bib0920","doi-asserted-by":"crossref","first-page":"112+","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib0925","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/HYPERTENSIONAHA.111.00202","article-title":"Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy","volume":"61","author":"Chen","year":"2013","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib0930","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1165\/rcmb.2011-0289OC","article-title":"LPS-stimulated cytokine production in type I cells is modulated by the renin-angiotensin system","volume":"46","author":"Wong","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.biopha.2020.111193_bib0935","doi-asserted-by":"crossref","first-page":"104350","DOI":"10.1016\/j.yexmp.2019.104350","article-title":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway","volume":"113","author":"Ye","year":"2020","journal-title":"Exp. Mol. Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0940","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00408-013-9470-8","article-title":"ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats","volume":"191","author":"Li","year":"2013","journal-title":"Lung"},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib0945","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/10641963.2019.1583247","article-title":"Angiotensin-converting enzyme 2 activation suppresses pulmonary vascular remodeling by inducing apoptosis through the Hippo signaling pathway in rats with pulmonary arterial hypertension","volume":"41","author":"Yan","year":"2019","journal-title":"Clin. Exp. Hypertens."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib0950","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11596-019-2073-8","article-title":"Dynamic variation of RAS on silicotic fibrosis pathogenesis in rats","volume":"39","author":"Zhang","year":"2019","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.biopha.2020.111193_bib0955","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.taap.2016.06.026","article-title":"Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model","volume":"306","author":"Dhawale","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0960","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/08958378.2013.850563","article-title":"Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease","volume":"26","author":"Xue","year":"2014","journal-title":"Inhal. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0965","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1183\/09031936.00015612","article-title":"Cell cycle dependence of ACE-2 explains downregulation in idiopathic pulmonary fibrosis","volume":"42","author":"Uhal","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2020.111193_bib0970","article-title":"Cell differentiation and aging accompanied by depletion of the ACE2 protein","volume":"12","author":"B\u00e1rtov\u00e1","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"Pt 11","key":"10.1016\/j.biopha.2020.111193_bib0975","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1099\/vir.0.2008\/003962-0","article-title":"Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2","volume":"89","author":"Mathewson","year":"2008","journal-title":"J. Gen. Virol."},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib0980","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1074\/jbc.M508381200","article-title":"SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells","volume":"281","author":"Huang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2020.111193_bib0985","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-0-387-33012-9_37","article-title":"Attachment factor and receptor engagement of SARS coronavirus and human coronavirus NL63","volume":"581","author":"Hofmann","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib0990","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib0995","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2020.02.071","article-title":"Structure analysis of the receptor binding of 2019-nCoV","volume":"525","author":"Chen","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.biopha.2020.111193_bib1000","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.7150\/ijms.46695","article-title":"A comprehensive investigation of the mRNA and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells","volume":"17","author":"Wang","year":"2020","journal-title":"Int. J. Med. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2020.111193_bib1005","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.peptides.2005.01.009","article-title":"Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents","volume":"26","author":"Gembardt","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2020.111193_bib1010","doi-asserted-by":"crossref","first-page":"2001123","DOI":"10.1183\/13993003.01123-2020","article-title":"Gene expression and <em>in situ<\/em> protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue","author":"Aguiar","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2020.111193_bib1015","article-title":"Activation of the SARS-CoV-2 receptor Ace2 by cytokines through pan JAK-STAT enhancers","author":"Hennighausen","year":"2020","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.biopha.2020.111193_bib1020","doi-asserted-by":"crossref","first-page":"e9610","DOI":"10.15252\/msb.20209610","article-title":"The protein expression profile of ACE2 in human tissues","volume":"16","author":"Hikmet","year":"2020","journal-title":"Mol. Syst. Biol."},{"issue":"October","key":"10.1016\/j.biopha.2020.111193_bib1025","article-title":"Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but strong virus-induced immune activation in alveolar macrophages","volume":"6","author":"H\u00f6nzke","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib1030","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1164\/rccm.202001-0179LE","article-title":"Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2","volume":"202","author":"Zhao","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.biopha.2020.111193_bib1035","doi-asserted-by":"crossref","DOI":"10.3390\/v12101174","article-title":"Expression pattern of the SARS-CoV-2 entry genes ACE2 and TMPRSS2 in the respiratory tract","volume":"12","author":"Liu","year":"2020","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib1040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cell.2020.05.042","article-title":"SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract","volume":"182","author":"Hou","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib1045","doi-asserted-by":"crossref","first-page":"e01928","DOI":"10.1128\/mBio.01928-20","article-title":"Antiviral activity of type I, II, and III interferons counterbalances ACE2 inducibility and restricts SARS-CoV-2","volume":"11","author":"Busnadiego","year":"2020","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.biopha.2020.111193_bib1050","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41587-020-0602-4","article-title":"COVID-19 severity correlates with airway epithelium\u2013immune cell interactions identified by single-cell analysis","volume":"38","author":"Chua","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2020.111193_bib1055","article-title":"Activation of ACE2 and interferon-stimulated transcriptomes in human airway epithelium is curbed by Janus kinase inhibitors","author":"Lee","year":"2020","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1060","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1038\/s41467-020-18781-2","article-title":"Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium","volume":"11","author":"Sajuthi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2020.111193_bib1065","article-title":"Enhanced expression of ACE2 in psoriatic skin and its upregulation in keratinocytes by interferon-gamma: implication of inflammatory milieu in skin tropism of SARS-CoV-2","author":"Tembhre","year":"2020","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib1070","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2020.111193_bib1075","article-title":"SARS-CoV-2 receptor Angiotensin I-converting enzyme type 2 is expressed in human pancreatic islet \u03b2-cells and is upregulated by inflammatory stress","author":"Fignani","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1080","article-title":"Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in rheumatoid synovium","author":"Mokuda","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1085","article-title":"Intestinal receptor of SARS-CoV-2 in inflamed IBD tissue seems downregulated by HNF4A in ileum and upregulated by interferon regulating factors in colon","author":"Verstockt","year":"2020","journal-title":"J. Crohns Colitis"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40249-020-00662-x","article-title":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues","volume":"9","author":"Li","year":"2020","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.biopha.2020.111193_bib1095","article-title":"Effects of asthma and human rhinovirus A16 on the expression of the SARS-CoV-2 entry factors in human airway epithelium","volume":"18","author":"Murphy","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol. Sep."},{"key":"10.1016\/j.biopha.2020.111193_bib1100","article-title":"Higher pharyngeal epithelial gene expression of Angiotensin-Converting Enzyme-2 in upper respiratory infection patients","author":"Zhang","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.biopha.2020.111193_bib1105","article-title":"SARS-CoV-2 activates lung epithelia cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients by single-cell sequencing","author":"Chen","year":"2020","journal-title":"medRxiv"},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib1110","doi-asserted-by":"crossref","DOI":"10.1177\/1470320320928872","article-title":"In vitro analysis of the renin-angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirus","volume":"21","author":"Turk","year":"2020","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1115","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12931-020-01445-6","article-title":"SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis","volume":"21","author":"Xu","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.biopha.2020.111193_bib1120","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59177","article-title":"A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm","volume":"9","author":"Garvin","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2020.111193_bib1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.07.007","article-title":"elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1\u03b1\/glycolysis-dependent axis","author":"Codo","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2020.111193_bib1130","doi-asserted-by":"crossref","first-page":"568954","DOI":"10.3389\/fmolb.2020.568954","article-title":"Identifying pathways and networks associated with the SARS-CoV-2 cell receptor ACE2 based on gene expression profiles in normal and SARS-CoV-2-Infected human tissues","volume":"7","author":"Feng","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2020.111193_bib1135","article-title":"Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection","author":"Zhuang","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.biopha.2020.111193_bib1140","article-title":"Interferons and viruses induce a novel primate-specific isoform dACE2 and not the SARS-CoV-2 receptor ACE2","author":"Onabajo","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1145","article-title":"A novel isoform of <em>ACE2<\/em> is expressed in human nasal and bronchial respiratory epithelia and is upregulated in response to RNA respiratory virus infection","author":"Blume","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1150","doi-asserted-by":"crossref","DOI":"10.1038\/s41588-020-00732-8","article-title":"Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option","author":"Ng","year":"2020","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib1155","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including Interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2020.111193_bib1160","article-title":"SARS-CoV-2 desensitizes host cells to interferon through inhibition of the JAK-STAT pathway","author":"Chen","year":"2020","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib1165","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/cid\/ciaa410","article-title":"Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19","volume":"71","author":"Chu","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2020.111193_bib1170","article-title":"SARS-CoV-2 infection suppresses ACE2 function and antiviral immune response in the upper respiratory tract of infected patients","author":"Guti\u00e9rrez-Chamorro","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1175","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa332","article-title":"ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19","author":"Pinto","year":"2020","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2020.111193_bib1180","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/CS20130291","article-title":"Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress","volume":"126","author":"Clarke","year":"2014","journal-title":"Clin. Sci. (Lond)"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.20138","article-title":"Persistent infection of SARS coronavirus in colonic cells in vitro","volume":"74","author":"Chan","year":"2004","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib1190","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1128\/JVI.79.6.3846-3850.2005","article-title":"Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication","volume":"79","author":"Mossel","year":"2005","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib1195","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/JVI.01702-06","article-title":"Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor","volume":"81","author":"Tseng","year":"2007","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2005.06.061","article-title":"Susceptibility of human and rat neural cell lines to infection by SARS-coronavirus","volume":"334","author":"Yamashita","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1205","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.chom.2020.05.020","article-title":"A mouse model of SARS-CoV-2 infection and pathogenesis","volume":"28","author":"Sun","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.biopha.2020.111193_bib1210","article-title":"Systemic analysis of putative SARS-CoV-2 entry and processing genes in cardiovascular tissues identifies a positive correlation of BSG with age in endothelial cells","author":"Ahmetaj-Shala","year":"2020","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib1215","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1086\/427811","article-title":"Function of HAb18G\/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus","volume":"191","author":"Chen","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2020.111193_bib1220","article-title":"CD147 (<em>BSG<\/em>) but not <em>ACE2<\/em> expression is detectable in vascular endothelial cells within single cell RNA sequencing datasets derived from multiple tissues in healthy individuals","author":"Ganier","year":"2020","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1225","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","article-title":"CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2020.111193_bib1230","article-title":"CD209L\/L-SIGN and CD209\/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells","author":"Amraie","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1235","article-title":"SARS-CoV-2 spike protein interacts with multiple innate immune receptors","author":"Gao","year":"2020","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib1240","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virol.2005.06.026","article-title":"LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus","volume":"340","author":"Gramberg","year":"2005","journal-title":"Virology"},{"issue":"44","key":"10.1016\/j.biopha.2020.111193_bib1245","doi-asserted-by":"crossref","first-page":"15748","DOI":"10.1073\/pnas.0403812101","article-title":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus","volume":"101","author":"Jeffers","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"21","key":"10.1016\/j.biopha.2020.111193_bib1250","doi-asserted-by":"crossref","first-page":"12090","DOI":"10.1128\/JVI.78.21.12090-12095.2004","article-title":"DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus","volume":"78","author":"Marzi","year":"2004","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.biopha.2020.111193_bib1255","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1128\/JVI.78.11.5642-5650.2004","article-title":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN","volume":"78","author":"Yang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2020.111193_bib1260","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system","author":"Cantuti-Castelvetri","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1265","article-title":"Neuropilin-1 is a host factor for SARS-CoV-2 infection","author":"Daly","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1270","article-title":"Binding of the SARS-CoV-2 spike protein to glycans","author":"Hao","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1275","article-title":"SARS-CoV-2 spike protein binds heparan sulfate in a length- and sequence-dependent manner","author":"Liu","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1280","article-title":"KIM-1\/TIM-1 is a receptor for SARS-CoV-2 in lung and kidney","author":"Ichimura","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1285","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.0c17044","article-title":"Non-receptor-Mediated lipid membrane permeabilization by the SARS-CoV-2 spike protein S1 subunit","author":"Asandei","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"21","key":"10.1016\/j.biopha.2020.111193_bib1290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218081","article-title":"Emerging mechanisms of pulmonary vasoconstriction in SARS-CoV-2-Induced acute respiratory distress syndrome (ARDS) and potential therapeutic targets","volume":"21","author":"Karmouty-Quintana","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2020.111193_bib1295","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.2147\/IDR.S265718","article-title":"Role of renin-angiotensin system in acute lung injury caused by viral infection","volume":"13","author":"Gao","year":"2020","journal-title":"Infect. Drug Resist."},{"issue":"21","key":"10.1016\/j.biopha.2020.111193_bib1300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218038","article-title":"Renin-angiotensin system: an important player in the pathogenesis of acute respiratory distress syndrome","volume":"21","author":"Hrenak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2020.111193_bib1305","doi-asserted-by":"crossref","first-page":"19840","DOI":"10.1038\/srep19840","article-title":"Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus","volume":"6","author":"Gu","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1310","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1038\/ncomms4594","article-title":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections","volume":"5","author":"Zou","year":"2014","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib1315","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/CCM.0b013e3181c03009","article-title":"Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets","volume":"38","author":"Treml","year":"2010","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.biopha.2020.111193_bib1320","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1038\/srep07027","article-title":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury","volume":"4","author":"Yang","year":"2014","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.biopha.2020.111193_bib1325","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1111\/bph.15082","article-title":"A hypothesis for pathobiology and treatment of COVID-19: the centrality of ACE1\/ACE2 imbalance","volume":"177","author":"Sriram","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1330","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/HYPERTENSIONAHA.119.14071","article-title":"Ang II (Angiotensin II) conversion to angiotensin-(1-7) in the circulation is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting enzyme 2)-Independent","volume":"75","author":"Serfozo","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2020.111193_bib1335","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1038\/ncomms4595","article-title":"Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients","volume":"5","author":"Huang","year":"2014","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib1340","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s001340051152","article-title":"Angiotensin II formation and endothelin clearance in ARDS patients in supine and prone positions","volume":"26","author":"Wenz","year":"2000","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1345","doi-asserted-by":"crossref","first-page":"R24","DOI":"10.1186\/cc8887","article-title":"Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis","volume":"14","author":"Doerschug","year":"2010","journal-title":"Critical Care (London, England)"},{"key":"10.1016\/j.biopha.2020.111193_bib1350","article-title":"Coronavirus disease 2019 (COVID-19) is associated with low circulating plasma levels of angiotensin 1 and angiotensin 1,7","author":"Henry","year":"2020","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib1355","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.biopha.2020.111193_bib1360","article-title":"High rate of increased level of plasma Angiotensin II and its gender difference in COVID-19: an analysis of 55 hospitalized patients with COVID-19 in a single hospital, Wuhan, China","author":"Liu","year":"2020","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1365","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s13054-020-03015-0","article-title":"Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients","volume":"24","author":"Wu","year":"2020","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.biopha.2020.111193_bib1370","doi-asserted-by":"crossref","first-page":"E188","DOI":"10.1002\/ajh.25882","article-title":"Increased sFLT-1\/PlGF ratio in COVID-19: a novel link to angiotensin II-mediated endothelial dysfunction","volume":"95","author":"Giardini","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib1375","first-page":"453","article-title":"Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19","volume":"39","author":"Dudoignon","year":"2020","journal-title":"Anaesth. Crit. Care Pain Med."},{"issue":"7","key":"10.1016\/j.biopha.2020.111193_bib1380","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.3390\/jcm9072315","article-title":"The plasmatic aldosterone and C-reactive protein levels, and the severity of Covid-19: the Dyhor-19 study","volume":"9","author":"Villard","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2020.111193_bib1385","doi-asserted-by":"crossref","DOI":"10.1016\/j.pcad.2020.07.006","article-title":"Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): a preliminary report","author":"Henry","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.biopha.2020.111193_bib1390","article-title":"Serum ACE-2, angiotensin II, and aldosterone levels are unchanged in patients with COVID-19","author":"Rieder","year":"2020","journal-title":"Am. J. Hypertens."},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib1395","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s15010-020-01440-5","article-title":"Clinical characteristics of 194 cases of COVID-19 in Huanggang and Taian, China","volume":"48","author":"Zhang","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.biopha.2020.111193_bib1400","article-title":"Transcriptional response of signalling pathways to SARS-CoV-2 infection in normal human bronchial epithelial cells","author":"Enes","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1405","article-title":"A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient","author":"Nagy","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.biopha.2020.111193_bib1410","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbi.2020.04.046","article-title":"Current status of potential therapeutic candidates for the COVID-19 crisis","volume":"87","author":"Zhang","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.biopha.2020.111193_bib1415","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.120.15841","article-title":"Plasma angiotensin peptide profiling and ACE2-Activity in COVID-19 patients treated with pharmacological blockers of the renin angiotensin system","author":"Kintscher","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2020.111193_bib1420","article-title":"How important is the assessment of soluble ACE-2 in COVID-19?","author":"Rojas","year":"2020","journal-title":"Am. J. Hypertens."},{"issue":"11","key":"10.1016\/j.biopha.2020.111193_bib1425","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1038\/s41366-020-00689-y","article-title":"Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections","volume":"44","author":"Schlicht","year":"2020","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biopha.2020.111193_bib1430","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2018.03.015","article-title":"Reduction of soluble dipeptidyl peptidase 4 levels in plasma of patients infected with Middle East respiratory syndrome coronavirus","volume":"518","author":"Inn","year":"2018","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib1435","doi-asserted-by":"crossref","first-page":"A1012","DOI":"10.1016\/j.chest.2020.08.942","article-title":"A remarkable response to angiotensin II therapy in severe SARS-COV-2 infection","volume":"158","author":"Goetz","year":"2020","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.biopha.2020.111193_bib1440","first-page":"e0230","article-title":"Physiologic response to angiotensin II treatment for coronavirus disease 2019-Induced vasodilatory shock: a retrospective matched cohort study","volume":"2","author":"Leisman","year":"2020","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.biopha.2020.111193_bib1445","article-title":"Angiotensin II administration in patients with COVID-19 shock","author":"Ofosu-Barko","year":"2020","journal-title":"Crit. Pathw. Cardiol."},{"issue":"10","key":"10.1016\/j.biopha.2020.111193_bib1450","doi-asserted-by":"crossref","first-page":"C945","DOI":"10.1152\/ajpcell.00346.2012","article-title":"Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry","volume":"304","author":"Grobe","year":"2013","journal-title":"Am. J. Physiol., Cell Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib1455","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1113\/expphysiol.2007.040014","article-title":"Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages","volume":"93","author":"Gurley","year":"2008","journal-title":"Exp. Physiol."},{"issue":"12","key":"10.1016\/j.biopha.2020.111193_bib1460","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1161\/STROKEAHA.112.667063","article-title":"Impact of ACE2 deficiency and oxidative stress on cerebrovascular function with aging","volume":"43","author":"Pe\u00f1a Silva","year":"2012","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib1465","doi-asserted-by":"crossref","first-page":"e00264","DOI":"10.1002\/phy2.264","article-title":"ACE2 deficiency increases NADPH-mediated oxidative stress in the kidney","volume":"2","author":"Wysocki","year":"2014","journal-title":"Physiol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1470","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/HYPERTENSIONAHA.109.138420","article-title":"Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension","volume":"55","author":"Wysocki","year":"2010","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.biopha.2020.111193_bib1475","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects","volume":"52","author":"Haschke","year":"2013","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib1480","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00380-016-0877-z","article-title":"Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization","volume":"32","author":"Hisatake","year":"2017","journal-title":"Heart Vessels"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1485","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","article-title":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome","volume":"21","author":"Khan","year":"2017","journal-title":"Crit Care"},{"issue":"11","key":"10.1016\/j.biopha.2020.111193_bib1490","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S2213-2600(20)30418-5","article-title":"Human recombinant soluble ACE2 in severe COVID-19","volume":"8","author":"Zoufaly","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib1495","doi-asserted-by":"crossref","first-page":"L631","DOI":"10.1152\/ajplung.90415.2008","article-title":"Role of HIF-1alpha in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells","volume":"297","author":"Zhang","year":"2009","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib1500","doi-asserted-by":"crossref","first-page":"L547","DOI":"10.1152\/ajplung.00387.2018","article-title":"MiRNA let-7b promotes the development of hypoxic pulmonary hypertension by targeting ACE2","volume":"316","author":"Zhang","year":"2019","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib1505","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114844","article-title":"An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels","volume":"86","author":"Rigat","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2020.111193_bib1510","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2350-13-76","article-title":"Association between insertion\/deletion polymorphism in angiotensin-converting enzyme gene and acute lung injury\/acute respiratory distress syndrome: a meta-analysis","volume":"13","author":"Matsuda","year":"2012","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.biopha.2020.111193_bib1515","article-title":"ACE gene polymorphism and severe lung injury in patients with COVID-19","author":"Zheng","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib1520","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/rccm.2108086","article-title":"Angiotensin converting enzyme insertion\/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome","volume":"166","author":"Marshall","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.biopha.2020.111193_bib1525","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145102","article-title":"Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome","volume":"762","author":"G\u00f3mez","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.biopha.2020.111193_bib1530","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.11.012","article-title":"Angiotensin converting enzyme genotypes and mortality from COVID-19: an ecological study","author":"Aung","year":"2020","journal-title":"J. Infect."},{"issue":"11","key":"10.1016\/j.biopha.2020.111193_bib1535","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00109-020-01981-0","article-title":"ACE polymorphisms and COVID-19-related mortality in Europe","volume":"98","author":"Bellone","year":"2020","journal-title":"J. Mol. Med. (Berl)"},{"issue":"9","key":"10.1016\/j.biopha.2020.111193_bib1540","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1373\/clinchem.2004.035436","article-title":"ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome","volume":"50","author":"Chiu","year":"2004","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1545","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ajmg.a.30779","article-title":"Identification of an alternative 5\u2019-untranslated exon and new polymorphisms of angiotensin-converting enzyme 2 gene: lack of association with SARS in the Vietnamese population","volume":"136","author":"Itoyama","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"issue":"20","key":"10.1016\/j.biopha.2020.111193_bib1550","doi-asserted-by":"crossref","first-page":"11429","DOI":"10.1128\/JVI.78.20.11429-11433.2004","article-title":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2","volume":"78","author":"Li","year":"2004","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1555","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40246-020-00272-6","article-title":"COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice","volume":"14","author":"Lutz","year":"2020","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.biopha.2020.111193_bib1560","article-title":"Broad and differential animal ACE2 receptor usage by SARS-CoV-2","author":"Zhao","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1565","article-title":"Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease","author":"Golden","year":"2020","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib1570","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus","volume":"81","author":"McCray","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2020.111193_bib1575","article-title":"Lethality of SARS-CoV-2 infection in K18 human angiotensin converting enzyme 2 transgenic mice","author":"Oladunni","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1580","article-title":"Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection","author":"Rathnasinghe","year":"2020","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.biopha.2020.111193_bib1585","first-page":"827","article-title":"Future drug discovery in renin-angiotensin-aldosterone system intervention","volume":"12","author":"Tamargo","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib1590","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/CIRCRESAHA.116.303603","article-title":"New approaches in the treatment of hypertension","volume":"116","author":"Oparil","year":"2015","journal-title":"Circ. Res."},{"issue":"18","key":"10.1016\/j.biopha.2020.111193_bib1595","doi-asserted-by":"crossref","first-page":"15532","DOI":"10.1074\/jbc.M212934200","article-title":"Novel peptide inhibitors of angiotensin-converting enzyme 2","volume":"278","author":"Huang","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"40","key":"10.1016\/j.biopha.2020.111193_bib1600","doi-asserted-by":"crossref","first-page":"11852","DOI":"10.1021\/ja0277226","article-title":"Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors","volume":"124","author":"Dales","year":"2002","journal-title":"J. Am. Chem. Soc."},{"issue":"17","key":"10.1016\/j.biopha.2020.111193_bib1605","doi-asserted-by":"crossref","first-page":"17996","DOI":"10.1074\/jbc.M311191200","article-title":"ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis","volume":"279","author":"Towler","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib1610","doi-asserted-by":"crossref","first-page":"R1293","DOI":"10.1152\/ajpregu.00339.2011","article-title":"Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays","volume":"301","author":"Pedersen","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib1615","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/HYPERTENSIONAHA.112.198622","article-title":"Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2","volume":"60","author":"Ye","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2020.111193_bib1620","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2016.01.007","article-title":"Angiotensin converting enzyme versus angiotensin converting enzyme-2 selectivity of MLN-4760 and DX600 in human and murine bone marrow-derived cells","volume":"774","author":"Joshi","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2020.111193_bib1625","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00109-015-1285-z","article-title":"Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2","volume":"93","author":"Patel","year":"2015","journal-title":"J. Mol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib1630","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/HYPERTENSIONAHA.107.108944","article-title":"Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents","volume":"51","author":"Hern\u00e1ndez Prada","year":"2008","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.biopha.2020.111193_bib1635","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/1087057111413919","article-title":"Prediction of off-target effects on angiotensin-converting enzyme 2","volume":"16","author":"Kulemina","year":"2011","journal-title":"J. Biomol. Screen."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib1640","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/HYPERTENSIONAHA.113.02856","article-title":"Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro","volume":"63","author":"Haber","year":"2014","journal-title":"Hypertension"},{"issue":"18","key":"10.1016\/j.biopha.2020.111193_bib1645","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1111\/bph.13946","article-title":"Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT2 receptor expression in a rat model of type1 diabetes","volume":"174","author":"Goru","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2020.111193_bib1650","first-page":"e13513","article-title":"An update on ACE2 amplification and its therapeutic potential","author":"Marquez","year":"2020","journal-title":"Acta Physiologica n\/a(n\/a)"},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib1655","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/HYPERTENSIONAHA.113.01337","article-title":"Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology","volume":"62","author":"Qi","year":"2013","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib1660","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/1440-1681.13251","article-title":"The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases","volume":"47","author":"Qaradakhi","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"17","key":"10.1016\/j.biopha.2020.111193_bib1665","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25173980","article-title":"Natural flavonoids as potential angiotensin-converting enzyme 2 inhibitors for anti-SARS-CoV-2","volume":"25","author":"Muchtaridi","year":"2020","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib1670","article-title":"Geranium and lemon essential oils and their active compounds downregulate angiotensin-converting enzyme 2 (ACE2), a SARS-CoV-2 spike receptor-binding domain, in epithelial cells","volume":"9","author":"Senthil Kumar","year":"2020","journal-title":"Plants (Basel)"},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib1675","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2220\/biomedres.36.219","article-title":"Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean","volume":"36","author":"Takahashi","year":"2015","journal-title":"Biomed. Res."},{"issue":"14","key":"10.1016\/j.biopha.2020.111193_bib1680","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1021\/acsomega.0c00772","article-title":"Investigation into SARS-CoV-2 resistance of compounds in garlic essential oil","volume":"5","author":"Thuy","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.biopha.2020.111193_bib1685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2017.07.016","article-title":"TMPRSS2: a potential target for treatment of influenza virus and coronavirus infections","volume":"142","author":"Shen","year":"2017","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib1690","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2020.111193_bib1695","article-title":"Novel ACE2-IgG1 fusions with improved activity against SARS-CoV2","author":"Iwanaga","year":"2020","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1700","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/s41467-020-16048-4","article-title":"Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig","volume":"11","author":"Lei","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib1705","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chom.2020.06.021","article-title":"Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2","volume":"28","author":"Case","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.biopha.2020.111193_bib1710","first-page":"e13426","article-title":"Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection","author":"Monteil","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2020.111193_bib1715","article-title":"An hACE2 peptide mimic blocks SARS-CoV-2 pulmonary cell infection","author":"Karoyan","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1720","article-title":"Engineered trimeric ACE2 binds viral spike protein and locks it in \u201cThree-up\u201d conformation to potently inhibit SARS-CoV-2 infection","author":"Guo","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2020.111193_bib1725","first-page":"eabe0075","article-title":"De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2","author":"Linsky","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.biopha.2020.111193_bib1730","article-title":"Engineered ACE2 receptor traps potently neutralize SARS-CoV-2","author":"Glasgow","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1735","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01283-20","article-title":"SARS-CoV-2 and three related coronaviruses utilize multiple ACE2 orthologs and are potently blocked by an improved ACE2-Ig","author":"Li","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2020.111193_bib1740","article-title":"High affinity modified ACE2 receptors prevent SARS-CoV-2 infection","author":"Higuchi","year":"2020","journal-title":"bioRxiv"},{"issue":"10","key":"10.1016\/j.biopha.2020.111193_bib1745","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1128\/JVI.79.10.5900-5906.2005","article-title":"Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants","volume":"79","author":"Sui","year":"2005","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.biopha.2020.111193_bib1750","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41423-020-0426-7","article-title":"Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor","volume":"17","author":"Chen","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1755","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1038\/s41467-020-18058-8","article-title":"A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction","volume":"11","author":"Ejemel","year":"2020","journal-title":"Nat. Commun."},{"issue":"6496","key":"10.1016\/j.biopha.2020.111193_bib1760","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.abc2241","article-title":"A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2","volume":"368","author":"Wu","year":"2020","journal-title":"Science"},{"issue":"7821","key":"10.1016\/j.biopha.2020.111193_bib1765","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","volume":"584","author":"Zost","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biopha.2020.111193_bib1770","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00802-20","article-title":"Competitive SARS-CoV-2 serology reveals most antibodies targeting the spike receptor-binding domain compete for ACE2 binding","volume":"5","author":"Byrnes","year":"2020","journal-title":"mSphere"},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1775","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/s41467-020-16256-y","article-title":"A human monoclonal antibody blocking SARS-CoV-2 infection","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2020.111193_bib1780","article-title":"Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus","author":"Wang","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2020.111193_bib1785","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.biopha.2020.111193_bib1790","doi-asserted-by":"crossref","first-page":"e00293","DOI":"10.1002\/prp2.293","article-title":"Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases","volume":"5","author":"Al-Bari","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"issue":"4","key":"10.1016\/j.biopha.2020.111193_bib1795","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijid.2004.04.012","article-title":"Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound","volume":"8","author":"Keyaerts","year":"2004","journal-title":"Int. J. Infect. Dis."},{"issue":"15","key":"10.1016\/j.biopha.2020.111193_bib1800","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2020.111193_bib1805","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.antiviral.2006.04.014","article-title":"Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction","volume":"74","author":"Ho","year":"2007","journal-title":"Antiviral Res."},{"issue":"3","key":"10.1016\/j.biopha.2020.111193_bib1810","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.antiviral.2009.12.001","article-title":"TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds","volume":"85","author":"Haga","year":"2010","journal-title":"Antiviral Res."},{"issue":"0","key":"10.1016\/j.biopha.2020.111193_bib1815","article-title":"The interaction of SARS-CoV-2 and other coronavirus with Angiotensin converting Enzyme 2 (ACE2) as their main receptor: therapeutic implications","volume":"0","author":"Davidson","year":"2020","journal-title":"Hypertension"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222031386X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222031386X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:05:55Z","timestamp":1760097955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222031386X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":363,"alternative-id":["S075333222031386X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.111193","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.111193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111193"}}